These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5212521)

  • 21. Cytokines levels in prostate adenocarcinomas.
    Bălăşoiu M; Turculeanu A; Avrămescu C; Comănescu V; Simionescu C; Mogoantă L
    Rom J Morphol Embryol; 2005; 46(3):179-82. PubMed ID: 16444302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in blood ghrelin levels in prostate cancer patients submitted to hormone suppressive treatment.
    Bertaccini A; Pernetti R; Marchiori D; Pagotto U; Palladoro F; Palmieri F; Vitullo G; Guidi M; Martorana G
    Anticancer Res; 2009 Apr; 29(4):1345-8. PubMed ID: 19414385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
    Yasuda K; Nagakawa O; Akashi T; Fujiuchi Y; Koizumi K; Komiya A; Saiki I; Fuse H
    Prostate; 2009 Mar; 69(4):346-51. PubMed ID: 19021204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemocoagulation disorders in a patient with prostatic cancer and hepatic cirrhosis].
    Merino J; García-Conde J; Benet I; Otero M
    Rev Clin Esp; 1976 Feb; 140(4):387-90. PubMed ID: 1265324
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis of malignancy of prostate.
    Kapoor N; Surange S; Gupta KN; Husainy MA; Faizi M
    Indian J Pathol Microbiol; 2004 Apr; 47(2):186-8. PubMed ID: 16295464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer.
    Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
    Urol Oncol; 2005; 23(1):16-21. PubMed ID: 15885578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe hemorrhagic diathesis as the first sign of a metastasizing prostatic carcinoma].
    Manrique R; Hörder MH
    Med Klin; 1965 Aug; 60(35):1393-7. PubMed ID: 5887468
    [No Abstract]   [Full Text] [Related]  

  • 28. Administration of estramustine in response to changes in the prostate-specific antigen and Karnofsky index in the treatment of prostate cancer.
    Pintér O; Molnár J; Tóth C; Szabó Z; Lipták J; Fél P; Papp G; Hollman E; Hazay L; Streit B; Kisbenedek L; Fehér M; Kocsis I; Pajor L
    In Vivo; 2005; 19(4):787-92. PubMed ID: 15999550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical remission after resection of prostate cancer lung metastasis.
    Chao DH; Higgins JP; Brooks JD
    Urology; 2004 Mar; 63(3):584-5. PubMed ID: 15028469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trousseau's syndrome in a patient with metastatic prostate cancer.
    Rodriguez R; Walsh PC
    J Urol; 2000 Jun; 163(6):1877. PubMed ID: 10799213
    [No Abstract]   [Full Text] [Related]  

  • 31. [Levels of cadmium, zinc, copper and selenium in subjects with diagnosed prostate cancer].
    Daragó A; Sapota A; Duda-Szymańska J
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():39-40. PubMed ID: 12884501
    [No Abstract]   [Full Text] [Related]  

  • 32. Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan.
    Sekine Y; Ito K; Yamamoto T; Nakazato H; Shibata Y; Hatori M; Suzuki K
    Cancer Detect Prev; 2007; 31(2):149-53. PubMed ID: 17418977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer: 7. Radiation therapy for localized disease.
    Warde P; Catton C; Gospodarowicz MK
    CMAJ; 1998 Dec; 159(11):1381-8. PubMed ID: 9861209
    [No Abstract]   [Full Text] [Related]  

  • 34. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R; Kelly LJ; Chan YK
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypofibrinogenemic hemorrhagic diathesis in prostatic carcinoma].
    Ohler WG; Fischer J; Enders W; Kikillus B
    Dtsch Med Wochenschr; 1966 Jan; 91(3):119-24. PubMed ID: 5901817
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha-1-antitrypsin deficiency, bleeding diathesis, and intracranial haemorrhage.
    Jenkins HR; Leonard JV; Kay JD; Pool RW; Sills JA; Isherwood DM
    Arch Dis Child; 1982 Sep; 57(9):722-3. PubMed ID: 6982029
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypofibrinogenemia and fibrinolysis in metastatic cancer of the prostate as a rare cause of unilateral renal hemorrhage].
    STEFAN H; CHROBAK L; GROH J
    Cas Lek Cesk; 1960 Mar; 99():302-6. PubMed ID: 13833992
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate.
    TAGNON HJ; SCHULMAN P; WHITMORE WF; LEONE LA
    Am J Med; 1953 Dec; 15(6):875-84. PubMed ID: 13104458
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prostate cancer with hemorrhagic diathesis].
    MEUWISSEN T; ZAMAN CL
    Ned Tijdschr Geneeskd; 1956 Jun; 100(24):1697-702. PubMed ID: 13348733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.